Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Suazo Zepeda, E."'
Quality of life after treatment with immune checkpoint inhibitors for lung cancer; the impact of age
Autor:
Suazo-Zepeda, E., Vinke, P.C., Heuvelmans, M.A., Sidorenkov, G., Hiltermann, T.J.N., de Bock, G.H.
Publikováno v:
In Lung Cancer February 2023 176:89-97
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Suazo-Zepeda E; Unit of Oncological Epidemiology, Department of Epidemiology, Graduate School of Medical Sciences, University of Groningen, Groningen, The Netherlands., Maas WJ; Unit of Oncological Epidemiology, Department of Epidemiology, Graduate School of Medical Sciences, University of Groningen, Groningen, The Netherlands., Vinke PC; Unit of Oncological Epidemiology, Department of Epidemiology, Graduate School of Medical Sciences, University of Groningen, Groningen, The Netherlands., Hiltermann TJN; Department of Pulmonology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Aarts MJ; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands., de Bock GH; Unit of Oncological Epidemiology, Department of Epidemiology, Graduate School of Medical Sciences, University of Groningen, Groningen, The Netherlands., Heuvelmans MA; Unit of Oncological Epidemiology, Department of Epidemiology, Graduate School of Medical Sciences, University of Groningen, Groningen, The Netherlands.
Publikováno v:
Translational lung cancer research [Transl Lung Cancer Res] 2024 Sep 30; Vol. 13 (9), pp. 2202-2211. Date of Electronic Publication: 2024 Sep 20.
Autor:
McClellan SP; Department of Family and Community Medicine, University of California San Francisco, San Francisco, CA, USA., Unger-Saldaña K; Epidemiology Research Unit, National Institute of Cancer, Mexico City, Mexico., Espinosa-Tamez P; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA., Suazo-Zepeda E; Center for Research on Population Health, National Institute of Public Health, Mexico City, Mexico., Potter MB; Department of Family and Community Medicine, University of California San Francisco, San Francisco, CA, USA., Barquet-Muñoz SA; Department of Gynecology, National Institute of Cancer, Mexico City, Mexico., Torres-Ibarra L; Center for Research on Population Health, National Institute of Public Health, Mexico City, Mexico., Lamadrid-Figueroa H; Department of Perinatal Health, National Institute of Public Health, Cuernavaca, Mexico., Lajous M; Center for Research on Population Health, National Institute of Public Health, Mexico City, Mexico.; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Publikováno v:
Health systems and reform [Health Syst Reform] 2023 Dec 31; Vol. 9 (1), pp. 2272371. Date of Electronic Publication: 2023 Nov 09.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vinke PC; Epidemiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands p.c.vinke@umcg.nl susipuig@gmail.com., Combalia M; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain.; Dermatology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain., de Bock GH; Epidemiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Leyrat C; Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK., Spanjaart AM; Hematology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE, Amsterdam, The Netherlands., Dalle S; Dermatology, Cancer Research Center of Lyon, Lyon Sud Hospital, Pierre-Bénite, France.; University Claude Bernard Lyon 1, Villeurbanne, France.; ImmuCare, Cancer Institute of the Hospices Civils de Lyon, Lyon, France., Gomes da Silva M; Hematology, Portuguese Institute of Oncology, Lisboa, Portugal., Fouda Essongue A; ImmuCare, Cancer Institute of the Hospices Civils de Lyon, Lyon, France., Rabier A; ImmuCare, Cancer Institute of the Hospices Civils de Lyon, Lyon, France., Pannard M; INSERM Unit U1296 Radiation: Defence, Health, Environment, Lumière University Lyon 2 Psychology Institute, Bron, France., Jalali MS; MGH Institute for Technology Assessment, Harvard Medical School, Boston, Massachusetts, USA., Elgammal A; Scientific Academy for Service Technology e.V. (ServTech), Potsdam, Germany.; Egypt University of Informatics, Cairo, Egypt., Papazoglou M; Scientific Academy for Service Technology e.V. (ServTech), Potsdam, Germany.; School of Computer Science and Engineering, University of New South Wales, Sydney, New South Wales, Australia.; School of Computing, Macquarie University, Sydney, New South Wales, Australia., Hacid MS; LIRIS, CNRS UMR 5205, Universite Claude Bernard Lyon 1, Villeurbanne, France., Rioufol C; Clinical Oncology Pharmacy Department, Hospital Lyon-South, Cancer Institute of the Hospices Civils de Lyon, Pierre-Benite, France., Kersten MJ; Hematology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE, Amsterdam, The Netherlands., van Oijen MG; Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands., Suazo-Zepeda E; Epidemiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Malhotra A; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK., Coquery E; LIRIS, CNRS UMR 5205, Universite Claude Bernard Lyon 1, Villeurbanne, France., Anota A; Direction of Clinical Research and Innovation & Human and Social Sciences, Centre Léon Bérard, Lyon, France.; French National platform Quality of Life and Cancer, Lyon, France., Preau M; INSERM Unit U1296 Radiation: Defence, Health, Environment, Lumière University Lyon 2 Psychology Institute, Bron, France., Fauvernier M; University Claude Bernard Lyon 1, Villeurbanne, France.; Service de Biostatistique et Bioinformatique, Hospices Civils de Lyon, Pôle Santé Publique, Lyon, France.; UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, CNRS, Villeurbanne, France., Coz E; University Claude Bernard Lyon 1, Villeurbanne, France.; Service de Biostatistique et Bioinformatique, Hospices Civils de Lyon, Pôle Santé Publique, Lyon, France.; UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, CNRS, Villeurbanne, France., Puig S; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain p.c.vinke@umcg.nl susipuig@gmail.com.; Dermatology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Enfermedades Raras, Barcelona, Spain., Maucort-Boulch D; University Claude Bernard Lyon 1, Villeurbanne, France.; Service de Biostatistique et Bioinformatique, Hospices Civils de Lyon, Pôle Santé Publique, Lyon, France.; UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, CNRS, Villeurbanne, France.
Publikováno v:
BMJ open [BMJ Open] 2023 Apr 27; Vol. 13 (4), pp. e069090. Date of Electronic Publication: 2023 Apr 27.
Autor:
Muntinghe, B., van Leer-Buter, C., Rozendal, P., Suazo Zepeda, E., Kievit, H., Verschuuren, E.A.M., Groen, H.J.M., Van Der Wekken, A.J., de Bock, G.H., Schuuring, E., Hiltermann, J.T.J.N.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S835-S835
Autor:
Suazo Zepeda, E., Heuvelmans, M.A., Aarts, M.J., Maas, W.J., Vinke, P.C., Hiltermann, J.T.J.N., de Bock, G.H.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S826-S826
Autor:
Unger-Saldaña K; Takemi Program in International Health, Harvard T.H. Chan School of Public Health, Boston, USA.; Epidemiology Research Unit, National Institute of Cancer, Mexico City, Mexico., Contreras-Manzano A; Center for Nutrition and Health Research, National Institute of Public Health (INSP), Cuernavaca, Mexico., Lamadrid-Figueroa H; Department of Perinatal Health, National Institute of Public Health (INSP), Cuernavaca, Mexico., Mohar A; Epidemiology Unit, Instituto de Investigaciones Biomédicas Universidad Nacional Autónoma de México and National Cancer Institute, Mexico City, Mexico., Suazo-Zepeda E; Center for Research on Population Health, National Institute of Public Health, Mexico City, Mexico., Espinosa-Tamez P; Center for Research on Population Health, National Institute of Public Health, Mexico City, Mexico., Lajous M; Center for Research on Population Health, National Institute of Public Health, Mexico City, Mexico.; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Reich MR; Takemi Program in International Health, Harvard T.H. Chan School of Public Health, Boston, USA.; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Publikováno v:
Health systems and reform [Health Syst Reform] 2022 Jan 01; Vol. 8 (1), pp. e2064794.
Autor:
Espinosa-Tamez P; Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Mexico City, Mexico / UCSF Helen Diller Family Comprehensive Cancer Center, University of California. San Francisco, CA, USA. priscilla.espinosatamez@ucsf.edu., Suazo-Zepeda E; Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Mexico City, Mexico. ericksu5259@gmail.com., Sánchez-Blas H; Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Mexico City, Mexico. hugoblass@outlook.com., Meneses-Medina M; Departamento de Hematología y Oncología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Mexico City, Mexico. mimm2404@hotmail.com., Huitzil-Meléndez FD; Departamento de Hematología y Oncología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Mexico City, Mexico. drdavidhuitzil@gmail.com., Van Loon K; UCSF Helen Diller Family Comprehensive Cancer Center, University of California. San Francisco, CA, USA. katherine.vanloon@ucsf.edu., Potter M; San Francisco Bay Area Collaborative Research Network, University of California San Francisco Clinical and Translational Science Institute. San Francisco, CA, USA. michael.potter@ucsf.edu., Lajous M; Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Mexico City, Mexico / Department of Global Health and Population, Harvard T.H. Chan School of Public Health. Boston, MA, USA. mlajous@insp.mx.
Publikováno v:
Salud publica de Mexico [Salud Publica Mex] 2021 Aug 02; Vol. 64 (1), pp. 5-13. Date of Electronic Publication: 2021 Aug 02.